Wells Fargo’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $500 | Sell |
459
-17,397
| -97% | -$19K | ﹤0.01% | 5910 |
|
2025
Q1 | $17.4K | Buy |
17,856
+875
| +5% | +$851 | ﹤0.01% | 5295 |
|
2024
Q4 | $25.1K | Buy |
16,981
+4,135
| +32% | +$6.12K | ﹤0.01% | 5207 |
|
2024
Q3 | $27.2K | Buy |
12,846
+359
| +3% | +$761 | ﹤0.01% | 5148 |
|
2024
Q2 | $30.5K | Buy |
12,487
+12,293
| +6,337% | +$30K | ﹤0.01% | 5092 |
|
2024
Q1 | $1.26K | Buy |
194
+40
| +26% | +$259 | ﹤0.01% | 5709 |
|
2023
Q4 | $594 | Buy |
154
+8
| +5% | +$31 | ﹤0.01% | 5902 |
|
2023
Q3 | $312 | Buy |
146
+10
| +7% | +$21 | ﹤0.01% | 6091 |
|
2023
Q2 | $415 | Buy |
136
+40
| +42% | +$122 | ﹤0.01% | 6220 |
|
2023
Q1 | $250 | Buy |
96
+2
| +2% | +$5 | ﹤0.01% | 6391 |
|
2022
Q4 | $193 | Buy |
94
+6
| +7% | +$12 | ﹤0.01% | 6301 |
|
2022
Q3 | $0 | Buy |
88
+38
| +76% | – | ﹤0.01% | 6612 |
|
2022
Q2 | $0 | Sell |
50
-5,697
| -99% | – | ﹤0.01% | 6776 |
|
2022
Q1 | $26K | Sell |
5,747
-6,952
| -55% | -$31.5K | ﹤0.01% | 5584 |
|
2021
Q4 | $151K | Buy |
+12,699
| New | +$151K | ﹤0.01% | 5045 |
|